Actively Recruiting
Phase III Study Evaluating Safety and Early Effects of JY016 Injection in Adults with Advanced EGFR-Expressing Solid Tumors
Led by Biotech Pharmaceutical Co., Ltd. · Updated on 2026-11-04
228
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating JY016 injection in patients with advanced solid tumors that express EGFR. This Phase III clinical trial includes a Phase I dose escalation stage to study the safety, pharmacokinetics, and early effectiveness of JY016 in patients whose tumors show EGFR expression by immunohistochemistry levels 1, 2, or 3. The Phase II expansion stage further assesses JY016s efficacy in specific cancers such as pancreatic, non-small cell lung, esophageal, colorectal, and squamous cell carcinoma of the head and neck with EGFR expression. Participants will receive JY016 according to planned doses during both study stages. The Phase I stage focuses on dose escalation to find the maximum tolerated dose and evaluate safety, while the Phase II stage expands to more patients with certain tumor types to better assess efficacy. JY016 is administered as an injection. The study does not include a placebo group and is open-label, meaning both researchers and participants know the treatment given. Throughout the trial, participants will be monitored for safety and response. Researchers will assess maximum tolerated dose during the first 4 weeks and track adverse events over about one year. They will measure drug concentration in blood and tumor response from enrollment up to 24 months. Participants will have regular assessments including physical exams, laboratory tests, imaging scans to measure tumor lesions, and evaluations of heart and organ function. The study duration may vary but includes long-term safety and efficacy follow-up.
CONDITIONS
Brief Title
JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here